Status:

UNKNOWN

Use of tDCS Applied to the Orbitofrontal Cortex to Improve Risky Decision-making in a Clinical Population

Lead Sponsor:

Centre Hospitalier St Anne

Conditions:

Mood Disorders

Depression

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Decision-making is a complex cognitive function that has been the subject of extensive scientific research in the fields of cognitive and computational neuroscience. It relies on a cerebral network th...

Detailed Description

The primary objective is to assess the ability of tDCS applied to the orbitofrontal cortex to improve decision-making, as measured by the Iowa Gambling Task, compared to a placebo stimulation in patie...

Eligibility Criteria

Inclusion

  • Patients under consideration should either be receiving outpatient or inpatient care.
  • Patients must be between the ages of 18 and 65, inclusive.
  • According to DSM-5 criteria, patients should be diagnosed with either unipolar or bipolar depressive disorder. This includes individuals currently experiencing a characterized depressive episode with mild to moderate intensity, those in partial remission, or those in full remission.
  • Patients must have provided informed consent.
  • Patients should be enrolled in a social security plan.

Exclusion

  • Patient unwilling to participate in the research.
  • Non-French-speaking individuals.
  • Individuals deprived of liberty by judicial or administrative decision, such as those under guardianship or curatorship or involuntarily hospitalized.
  • Pregnant or breastfeeding women.
  • Current hypomanic or manic episode as per DSM-5 criteria due to motor agitation issues.
  • Ongoing electroconvulsive therapy (ECT) treatment or within the last 6 months.
  • Patients with active implantable medical devices.
  • Epilepsy.

Key Trial Info

Start Date :

April 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 15 2024

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT06110559

Start Date

April 16 2021

End Date

May 15 2024

Last Update

November 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GHU Paris Psychiatrie et Neurosciences - Hôpital Sainte-Anne - CMME

Paris, France, 75014